Management of mTOR inhibitors oral mucositis: current state of knowledge

Journal of Oral Medicine and Oral Surgery

Rochefort Juliette¹  Descroix Vianney¹  Lescaille Géraldine¹  Javelot Marie José² 

[1] ;Oral Surgery Department;

关键词: mtor inhibitor;    stomatitis;    targeted anticancer treatments;   

DOI  :  10.1051/mbcb/2018027

来源: DOAJ

【 摘 要 】

Introduction: Mucositis is a well-known side effect of classic anticancer treatments (chemotherapy and radiotherapy). Thanks to the major developments in personalizing treatments through the development of targeted treatment, various specific intraoral lesions have been described. Purpose: mTOR inhibitors are targeted anticancer treatments that are used to treat various cancer types. They can cause intraoral ulcerations that can be serious, and that can lead to a dose reduction or the anticancer treatment being stopped altogether. The management of these disabling and painful lesions is a major part of ensuring the efficiency of the cancer treatments. The objective of this article is to evaluate the current knowledge about the different treatments used nowadays, especially the preventive treatments. Conclusion: An efficient management of the lesions is a major part of the management of patients treated with mTOR inhibitors and should be carried out by the oral cavity specialists.

【 授权许可】

Unknown